Quarterly report pursuant to Section 13 or 15(d)

ACQUISITIONS (Details Narrative)

v3.22.2
ACQUISITIONS (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 01, 2021
Jun. 30, 2022
Sep. 30, 2021
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Business Acquisition [Line Items]              
Fair value of contingent consideration $ 5,605,000            
Consideration paid 1,571,000            
Weighted average amortization period         3 years    
Revenue   $ 37,228,000   $ 34,065,000 $ 72,569,000 $ 63,834,000  
Difference between, actual revenue and pro forma revenue   37,228,000   42,169,000 72,569,000 81,624,000  
medSR [Member]              
Business Acquisition [Line Items]              
Earnout, payment 13,000,000            
Fair value of contingent consideration 5,600,000 1,900,000     1,900,000   $ 3,100,000
Consideration paid 1,500,000            
Revenue and backlog milestones, payments $ 500,000            
Additional shares held, terms 18 months            
Escrow, settlement     $ 250,000        
Working capital, adjustment     $ 250,000        
Escrow, deposit held         71,000    
Escrow, deposit   1,000,000     $ 1,000,000   1,000,000
Cash             $ 12,300,000
Weighted average amortization period         3 years    
Revenue   $ 8,600,000     $ 15,800,000    
Difference between, actual revenue and pro forma revenue       $ 8,100,000   $ 17,800,000  
Asset and Stock Purchase Agreement [Member] | MedMatica [Member]              
Business Acquisition [Line Items]              
Consideration paid $ 10,000,000            
Working capital deficiency 3,800,000            
Maximum earn-out payments based upon achievements 8,000,000            
Additional maximum earn-out payments based upon achievements $ 5,000,000